SPINOCEREBELLAR ATAXIA 17 (SCA17) DNA DETECTION / EDTA BLOOD

image not found

NABL Cap Accredited     
The Spinocerebellar Ataxia 17 (SCA17) DNA Detection test identifies pathogenic expansions in the TBP gene associated with SCA17. This inherited neurodegenerative disorder leads to progressive ataxia, cognitive decline, and movement abnormalities. The test helps confirm a clinical diagnosis, assess hereditary risk, and guide genetic counselling. Using EDTA blood, advanced molecular techniques accurately detect abnormal repeat expansions linked to the condition

  • 17 Crores+ Samples Processed
  • World Class Technology Labs
  • 25+ Years of Trust & Experience
  • Free Home Collection

Price: Rs. 3,390.00

Sample Type: EDTA BLOOD

Fasting Not Required


Notes: S0075

Frequently Asked Questions (FAQ's):

What is SCA17?
SCA17 is a hereditary neurodegenerative disorder caused by repeat expansion mutations in the TBP gene.

Why is this test done?
To confirm the genetic cause of suspected spinocerebellar ataxia and support clinical evaluation.

What sample is required?
EDTA blood is required for DNA extraction and analysis.

How is the test performed?
Advanced molecular methods, including PCR-based assays and fragment analysis, are used to detect TBP gene repeat expansions.

Is fasting needed before the test?
No, fasting or special preparation is not required.

Can this test help family members?
Yes, it assists in evaluating hereditary risk and is useful for genetic counselling in affected families.

What symptoms may suggest SCA17?
Ataxia, coordination problems, cognitive impairment, psychiatric symptoms, and involuntary movements.

Does Metropolis Healthcare offer this test?
Yes, Metropolis Healthcare provides accurate and reliable DNA-based testing for SCA17

OUR corporates PARTNER

Feedback

Patient's Testimonials

Trusted by Thousands

OUR Accreditations

OUR Lab